Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies
- PMID: 21742372
- DOI: 10.1016/j.ygyno.2011.06.012
Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies
Abstract
Objective: The purpose of this study was to investigate the incidence of mechanical complications associated with low-profile subcutaneous implantable venous access devices in gynecologic oncology patients.
Methods: Gynecologic oncology patients with low-profile Port-a-Caths implanted between March 2005 and July 2006 were identified into a computerized database. Patient demographics, operative complications, number of chemotherapy cycles, duration of implantation, and mechanical complications were collected. Primary outcomes included port leakage, catheter fracture, and catheter embolization.
Results: 112 patients underwent 115 Port-a-Cath placements with low profile single-lumen plastic ports with Groshong-valved catheters. Mean Port-a-Cath indwelling duration was 197 days (range: 4-395) with a mean number of 12 chemotherapy cycles (range 0-64). The cumulative complication rate necessitating removal or replacement was 15%. Of the 14 Port-a-Caths removed, ten (8.7%) were secondary to mechanical malfunction: one for leakage at the port site, two for catheter fracture, and seven for fracture with catheter embolization to the heart or pulmonary vasculature-most commonly the right ventricle. Patients with embolization were asymptomatic and all embolized catheters were successfully retrieved by interventional radiology without complications.
Conclusions: The rates of catheter fracture and embolization have previously been reported to be low in patients with subcutaneous Port-a-Caths, and have not been studied in patients receiving low-profile subcutaneous Port-a-Caths. This study suggests that catheter fracture may be more common (8.7%) and must be considered in patients with malfunctioning low-profile Port-a-Caths. Embolized catheters can be removed by interventional radiology without significant adverse affects.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Complications associated with an implantable vascular access device.J Pediatr Surg. 2006 Sep;41(9):1582-7. doi: 10.1016/j.jpedsurg.2006.05.022. J Pediatr Surg. 2006. PMID: 16952595
-
A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.Clin Oncol (R Coll Radiol). 2007 Sep;19(7):551-6. doi: 10.1016/j.clon.2007.04.003. Epub 2007 May 22. Clin Oncol (R Coll Radiol). 2007. PMID: 17517500
-
Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.Gynecol Oncol. 1993 Dec;51(3):372-6. doi: 10.1006/gyno.1993.1306. Gynecol Oncol. 1993. PMID: 8112648
-
A peripherally implanted permanent central venous access device.Obstet Gynecol. 1991 Dec;78(6):1138-42. Obstet Gynecol. 1991. PMID: 1945224 Review.
-
Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis.Eur J Cancer Care (Engl). 2010 Sep;19(5):676-81. doi: 10.1111/j.1365-2354.2009.01115.x. Epub 2009 Aug 25. Eur J Cancer Care (Engl). 2010. PMID: 19708941 Review.
Cited by
-
Long-term outcomes of totally implantable venous access devices.Support Care Cancer. 2017 Jul;25(7):2049-2054. doi: 10.1007/s00520-017-3592-0. Epub 2017 Feb 9. Support Care Cancer. 2017. PMID: 28181014
-
Comparison of PICC and TIVAP in chemotherapy for patients with thyroid cancer.Oncol Lett. 2020 Aug;20(2):1657-1662. doi: 10.3892/ol.2020.11732. Epub 2020 Jun 15. Oncol Lett. 2020. PMID: 32724407 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources